{"abstract":"The Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) is seeking input from the public on the following topics related to antibacterial drug development: Potential new study designs, proposed priorities for CDER guidances, and strategies intended to slow the rate of emerging resistance to antibacterial drugs. The purpose of this notice is to request information and comments from the public on these areas of focus.","action":"Notice; request for comments.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2013/05/31/2013-12925.html","cfr_references":[],"citation":"78 FR 32669","comment_url":null,"comments_close_on":"2013-07-30","correction_of":null,"corrections":[],"dates":"Submit either electronic or written comments by July 30, 2013 at 5 p.m. EST.","disposition_notes":null,"docket_ids":["Docket No. FDA-2013-N-0556"],"dockets":[],"document_number":"2013-12925","effective_on":null,"end_page":32670,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2013/05/31/2013-12925.xml","html_url":"https://www.federalregister.gov/documents/2013/05/31/2013-12925/new-approaches-to-antibacterial-drug-development-request-for-comments","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2013-12925?publication_date=2013-05-31","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2013-05-31/2013-12925/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":2899,"last_updated":"2026-07-26 08:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2013-05-31/pdf/2013-12925.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2013-12925.pdf?1369918206","publication_date":"2013-05-31","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2013/05/31/2013-12925.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2013-N-0556","supporting_documents_count":0,"docket_id":"FDA-2013-N-0556","regulation_id_number":null,"title":"New Approaches to Antibacterial Drug Development; Request for Comments","checked_regulationsdotgov_at":"2013-06-20T08:06:23Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":32669,"subtype":null,"title":"New Approaches to Antibacterial Drug Development; Request for Comments","toc_doc":"New Approaches to Antibacterial Drug Development","toc_subject":null,"topics":[],"type":"Notice","volume":78}